A sequencer service contract is the part of the purchase most likely to be underestimated, because it is the only major cost that arrives as a recurring annual line rather than a one-time number. A $985,000 instrument is a single, visible, memorable figure. A service contract at a tenth of that per year looks small by comparison in the year it is signed, and its true weight only becomes clear when you add up five years of it, watch it escalate annually, and set it against the delivered uptime it actually bought. This article is about seeing that full cost before you sign, and building the five-year total cost of ownership model that makes the instrument price look as small as it really is.
The figures used here are representative planning ranges and figures carried from a standard cost model, not sourced vendor pricing, which is not publicly available and varies widely by instrument, region, and negotiation. They are stated as ranges wherever a single number would imply a precision that does not exist, and every representative figure is flagged as such. Use them to build the shape of your own model, then replace them with your own quotes.
Key Takeaways
|
What a Standard Contract Covers
Service contracts come in tiers, and the differences between them are exactly the terms that matter when an instrument goes down. A basic tier typically covers scheduled preventive maintenance and parts, with service calls billed or prioritized below premium customers. A premium tier adds guaranteed response times, priority scheduling, and sometimes a loaner or backup arrangement, at a correspondingly higher annual price. The gap between tiers is not a minor upgrade; it is the difference between a fault resolved in a day and one resolved in a week, which for a program with turnaround commitments is the difference that matters most.
Read the coverage boundaries carefully, because that is where the real terms hide. Consumable parts that wear out on a schedule may or may not be included. Software updates and, importantly, major software version upgrades may be separate. Applications support, the help you call for when a run fails for reasons the team cannot diagnose, is frequently a distinct line from hardware service. The questions that surface these boundaries before signing are covered in Evaluating NGS Vendors: The Questions to Ask Before You Sign.
Uptime Guarantees and What They Exclude
A stated uptime guarantee, often a percentage such as 95%, sounds like a promise that the instrument will be available that share of the time. It usually is not quite that. Read the definition, because uptime guarantees are written by the party that pays out when they are missed, and the details determine whether the guarantee is worth anything.
Three things decide the real value of an uptime figure. First, what counts as downtime, and specifically when the clock starts: at your call, or at the engineer’s arrival, which can be very different numbers. Second, what is excluded, since scheduled maintenance, user error, facility problems, and consumable failures are commonly carved out, and a guarantee that excludes the most common causes of downtime guarantees little. Third, and most important, what the remedy actually is when the guarantee is missed. A guarantee whose penalty is a modest service credit is a weak instrument for protecting a program that loses far more than the credit’s value each day the instrument is down.
A Percentage Is Not a PromiseConsider what a 95% uptime guarantee permits: roughly 18 days of downtime a year while still meeting the target. If those days fall during a critical run window, the guarantee has been met and your program has still missed its commitments. The uptime percentage is a useful comparison point between contracts, but the exclusions and the remedy are what determine whether it protects you. Value the remedy against what a day of downtime actually costs your program, not against the reassurance the percentage provides. |
Preventive Maintenance and Calibration
Preventive maintenance is the part of the contract that quietly determines how often the reactive part is needed. Scheduled maintenance visits, typically one or more per year for a production instrument, keep the instrument within specification and catch developing problems before they become failures. The contract should state how many visits are included, what each covers, and whether the calibration and verification needed to keep the instrument performing to specification are part of the visit or billed separately.
For labs doing regulated or accredited work, this section carries extra weight, because documented calibration and maintenance records are part of what an inspection expects to see. Confirm that the contract’s maintenance documentation meets your quality system’s requirements, not just the vendor’s standard practice, and that the records are provided in a form you can retain. A maintenance visit that happens but is not documented to your standard is a gap you will discover at the worst possible time.
Parts Availability and Loaner Terms
The best response time is worth little if the part that failed is not in the region. Parts logistics are the hidden variable behind service quality, and they are worth asking about specifically: whether critical spare parts are held regionally or shipped from a central depot, what the typical parts lead time is for a major component, and whether the contract includes any provision for a loaner instrument or a backup arrangement during an extended repair. For a single-instrument lab, an extended outage with no loaner is an existential operational risk, and the loaner terms may matter more than any other line in the contract.
This is also where the earlier platform-roadmap question returns with financial consequences. Parts availability for an older, superseded instrument tends to decline over time, and a service contract that looks comprehensive today may cover a platform for which parts become slow or scarce in a few years. The full cost picture of owning the instrument, including reagents and consumables alongside service, is developed in How Much Does NGS Cost? Budgeting Instruments, Reagents, and Sequencing.
Building a Five-Year TCO Model
Put the pieces together across the amortization period and the instrument price stops looking like the main event. The model below uses representative figures for a production-scale program running 1,000 genomes a year: an instrument near $985,000, a service contract at the middle of the 8 to 12% range with modest annual escalation, and reagent and consumable spend carried from a standard cost model. Every figure is a planning estimate, not a quote.
Cost Component | Five-Year Total (Representative) | Share of TCO |
Instrument (capital) | ~$985,000 | ~20% |
Service contract (with escalation) | ~$530,000 | ~11% |
Reagents and consumables | ~$3,400,000 | ~69% |
Five-year total (excl. labor, storage) | ~$4,900,000 | 100% |
Table 2. Representative five-year total cost of ownership for a production-scale program at 1,000 genomes per year. Figures are planning estimates, not sourced vendor pricing. Labor, data storage, and facilities are excluded and add further cost. Service assumes the middle of the 8 to 12% range with modest annual escalation.
Two conclusions follow, and both change how the purchase should be evaluated. First, the instrument that gets the hardest negotiation is about a fifth of the lifetime cost, while reagents, which get almost none, are more than two thirds. Second, the service contract, though smaller than either, is the only line here priced fresh every year, which means it is the only one whose terms and escalation you are agreeing to for five years at the moment of signing. Negotiate the escalation cap as carefully as the first-year price, because the first year is the smallest year the contract will ever cost.
This five-year view is the one that belongs in the capital request and the platform decision, not the instrument price alone. The structured selection process it feeds is in Choosing an NGS Platform: A Lab Manager’s Selection and Procurement Guide, and the broader operational and budget context is in Next-Generation Sequencing in the Lab: A Manager’s Guide to Building, Budgeting, and Scaling NGS Capacity.
This article was produced under Lab Manager's AI Editorial Guidelines.

















